Inhibition of IL-25/IL-17RA improves immune-related adverse events of checkpoint inhibitors and reveals antitumor activity
==========================================================================================================================

* Xizi Hu
* Shoiab M Bukhari
* Carly Tymm
* Kieran Adam
* Shalom Lerrer
* Brian S Henick
* Robert J Winchester
* Adam Mor